45. Identification of predicted neoantigen vaccine candidates in follicular lymphoma patients

There is a need for new follicular lymphoma (FL) therapies without long-term complications of chemotherapy and with curative potential. We hypothesize that FL contains tumor-specific mutant antigens (TSMAs) that can be targeted by the immune system by vaccination.

Source: Cancer Genetics and Cytogenetics - May 31, 2020 Category: Genetics & Stem Cells Authors: Cody Ramirez, Felix Frenkel, Olga Plotnikova, Vladislav Belousov, Alexander Bagaev, Elena Ocheredko, Susanna Kiwala, Jasreet Hundal, Zachary Skidmore, Marcus Watkins, Michelle Becker-Hapak, Thomas Mooney, Jason Walker, Catrina Fronick, Robert Fulton, Robe Source Type: research